María Gómez‐Cañas

1.3k total citations
33 papers, 1.1k citations indexed

About

María Gómez‐Cañas is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, María Gómez‐Cañas has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 18 papers in Cellular and Molecular Neuroscience and 15 papers in Molecular Biology. Recurrent topics in María Gómez‐Cañas's work include Cannabis and Cannabinoid Research (27 papers), Neuroscience and Neuropharmacology Research (13 papers) and Pharmacological Receptor Mechanisms and Effects (9 papers). María Gómez‐Cañas is often cited by papers focused on Cannabis and Cannabinoid Research (27 papers), Neuroscience and Neuropharmacology Research (13 papers) and Pharmacological Receptor Mechanisms and Effects (9 papers). María Gómez‐Cañas collaborates with scholars based in Spain, Italy and United States. María Gómez‐Cañas's co-authors include Javier Fernández‐Ruíz, Eduardo Muñóz, Manuel Guzmán, M. Ruth Pazos, Carmen Navarrete, Nadine Jagerovic, Paula Morales, Carmen Guaza, María L. Bellido and Giovanni Appendino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

María Gómez‐Cañas

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
María Gómez‐Cañas Spain	18	801	367	277	148	98	33	1.1k
Carmen Navarrete Spain	21	720 0.9×	293 0.8×	322 1.2×	180 1.2×	101 1.0×	33	1.2k
Oscar Sasso Italy	22	943 1.2×	382 1.0×	492 1.8×	94 0.6×	129 1.3×	27	1.7k
Valentina Latina Italy	19	423 0.5×	324 0.9×	315 1.1×	78 0.5×	55 0.6×	32	1.1k
María L. Bellido Spain	18	569 0.7×	302 0.8×	471 1.7×	290 2.0×	73 0.7×	29	1.2k
М. Yu. Bobrov Russia	12	545 0.7×	325 0.9×	186 0.7×	84 0.6×	81 0.8×	52	861
Nicholas A. Jones United Kingdom	14	712 0.9×	535 1.5×	201 0.7×	134 0.9×	43 0.4×	27	1.1k
Leon Chang United States	14	639 0.8×	534 1.5×	493 1.8×	74 0.5×	126 1.3×	23	1.3k
Guillermo Moreno‐Sanz United States	17	822 1.0×	280 0.8×	219 0.8×	107 0.7×	116 1.2×	26	1.0k
Pietro Marini Italy	20	885 1.1×	487 1.3×	424 1.5×	179 1.2×	160 1.6×	45	1.5k
Jessica P. Alexander United States	6	602 0.8×	206 0.6×	268 1.0×	82 0.6×	182 1.9×	6	934

Countries citing papers authored by María Gómez‐Cañas

Since Specialization

Citations

This map shows the geographic impact of María Gómez‐Cañas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Gómez‐Cañas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Gómez‐Cañas more than expected).

Fields of papers citing papers by María Gómez‐Cañas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Gómez‐Cañas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Gómez‐Cañas. The network helps show where María Gómez‐Cañas may publish in the future.

Co-authorship network of co-authors of María Gómez‐Cañas

This figure shows the co-authorship network connecting the top 25 collaborators of María Gómez‐Cañas. A scholar is included among the top collaborators of María Gómez‐Cañas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Gómez‐Cañas. María Gómez‐Cañas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gómez‐Cañas, María, Mathias Winkler, Diego Caprioglio, et al.. (2025). Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (−) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives. European Journal of Medicinal Chemistry Reports. 14. 100262–100262. 1 indexed citations

Gómez‐Cañas, María, et al.. (2022). Endocannabinoid-Binding Receptors as Drug Targets. Methods in molecular biology. 2576. 67–94. 13 indexed citations

García, Concepción, Francisco Ruíz-Pino, Juan D. Unciti‐Broceta, et al.. (2021). Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis. Molecules. 26(24). 7643–7643. 16 indexed citations

García, Concepción, et al.. (2021). Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease. Molecules. 26(11). 3245–3245. 23 indexed citations

González‐Mariscal, Isabel, Mathias Winkler, Juan D. Unciti‐Broceta, et al.. (2021). (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice. Pharmacological Research. 169. 105492–105492. 16 indexed citations

García, Concepción, María Gómez‐Cañas, Carmen Navarrete, et al.. (2020). Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice. Molecular and Cellular Neuroscience. 110. 103583–103583. 23 indexed citations

García, Concepción, et al.. (2019). Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease. Molecules. 24(15). 2702–2702. 31 indexed citations

Río, Carmen del, Irene Cantarero, Belén Palomares, et al.. (2018). VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB₂ receptor‐dependent pathways. British Journal of Pharmacology. 175(19). 3813–3831. 31 indexed citations

García, Concepción, María Gómez‐Cañas, Belén Palomares, et al.. (2018). Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor. Journal of Neuroinflammation. 15(1). 19–19. 55 indexed citations

10.

Gómez‐Cañas, María, Paula Morales, Carmen Rodríguez‐Cueto, et al.. (2017). New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking. European Journal of Medicinal Chemistry. 127. 398–412. 16 indexed citations

11.

Río, Carmen del, Carmen Navarrete, Juan A. Collado, et al.. (2016). The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways. Scientific Reports. 6(1). 21703–21703. 75 indexed citations

12.

Deiana, Valeria, María Gómez‐Cañas, M. Ruth Pazos, et al.. (2016). Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties. European Journal of Medicinal Chemistry. 112. 66–80. 18 indexed citations

13.

Gómez‐Cañas, María, Paula Morales, Carmen Navarrete, et al.. (2016). Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile. Pharmacological Research. 110. 205–215. 26 indexed citations

14.

Morales, Paula, Sandra Blasco-Benito, Clara Andradas, et al.. (2015). Selective, Nontoxic CB₂ Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 58(5). 2256–2264. 31 indexed citations

15.

Gómez‐Cañas, María, Paula Morales, Dow P. Hurst, et al.. (2015). Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB 2 receptor antagonists. European Journal of Medicinal Chemistry. 101. 651–667. 14 indexed citations

16.

Moreno, Estefanía, Clara Andradas, Mireia Medrano, et al.. (2014). Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling. Journal of Biological Chemistry. 289(32). 21960–21972. 89 indexed citations

17.

Morales, Paula, Diana Vara‐Ciruelos, María Gómez‐Cañas, et al.. (2013). Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity. European Journal of Medicinal Chemistry. 70. 111–119. 38 indexed citations

18.

Decara, Juan, María Jesús Luque Rojas, Laura Hernández‐Folgado, et al.. (2013). Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21. Bioorganic & Medicinal Chemistry. 21(7). 1708–1716. 17 indexed citations

19.

Hernández‐Folgado, Laura, Rocı́o Girón, Paula Morales, et al.. (2012). Chromenopyrazoles: Non‐psychoactive and Selective CB₁ Cannabinoid Agonists with Peripheral Antinociceptive Properties. ChemMedChem. 7(3). 452–463. 27 indexed citations

20.

Dyduch, Karol, Tomasz Kościółek, María Gómez‐Cañas, et al.. (2012). Design and Synthesis of Novel Cannabinoid Ligands Based on a 1,2,3- triazole Scaffold. Letters in Drug Design & Discovery. 10(2). 169–172. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact